US Stock MarketDetailed Quotes

ONCT Oncternal Therapeutics

Watchlist

9.1000
+0.1000+1.11%

Close May 23 16:00 ET

26.93MMarket Cap-738P/E (TTM)

Oncternal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

32.19%-7.44M

12.37%-32.16M

28.69%-6.42M

53.93%-5.51M

-29.92%-9.26M

-27.46%-10.97M

-38.04%-36.7M

-36.06%-9M

-87.55%-11.97M

6.28%-7.13M

Net income from continuing operations

26.98%-8.39M

10.62%-39.48M

19.61%-9.16M

11.35%-9.86M

23.64%-8.97M

-15.98%-11.49M

-40.97%-44.17M

-41.21%-11.4M

-15.52%-11.13M

-52.84%-11.74M

Other non cash items

-10.81%33K

-2.79%174K

-28.57%25K

114.29%75K

-43.08%37K

-15.91%37K

5.92%179K

-20.45%35K

-18.60%35K

54.76%65K

Change In working capital

85.98%-135K

1,946.38%1.27M

36.64%869K

202.28%2.92M

-153.92%-1.55M

-33.01%-963K

94.69%-69K

312.00%636K

-265.79%-2.85M

259.04%2.87M

-Change in prepaid assets

-64.65%327K

225.25%2.62M

-33.97%383K

178.11%2.31M

-219.30%-989K

267.27%925K

-193.83%-2.1M

1,015.38%580K

-264.22%-2.95M

142.45%829K

-Change in payables and accrued expense

77.42%-487K

-216.55%-2.57M

-88.52%24K

37.55%315K

-139.70%-752K

-1,598.43%-2.16M

81.48%2.21M

239.33%209K

-88.79%229K

263.28%1.89M

-Change in other current liabilities

-8.11%-40K

36.31%-114K

54.29%-16K

31.43%-24K

43.08%-37K

15.91%-37K

-5.92%-179K

20.45%-35K

18.60%-35K

-54.76%-65K

-Change in other working capital

-78.76%65K

--1.33M

--478K

443.01%319K

--231K

--306K

----

95.52%-93K

----

Cash from discontinued investing activities

Operating cash flow

32.19%-7.44M

12.37%-32.16M

28.69%-6.42M

53.93%-5.51M

-29.92%-9.26M

-27.46%-10.97M

-38.04%-36.7M

-36.06%-9M

-87.55%-11.97M

6.28%-7.13M

Investing cash flow

Cash flow from continuing investing activities

145.01%7.22M

102.46%651K

93.18%-1.81M

4.66M

13.85M

-16.05M

-26.5M

Net investment purchase and sale

145.01%7.22M

102.46%651K

93.18%-1.81M

--4.66M

--13.85M

---16.05M

---26.5M

--0

Cash from discontinued investing activities

Investing cash flow

145.01%7.22M

102.46%651K

93.18%-1.81M

--4.66M

--13.85M

---16.05M

---26.5M

--0

Financing cash flow

Cash flow from continuing financing activities

-107.77%-87K

-88.85%1.07M

-100.05%-1K

-101.33%-49K

-100.03%-1K

1.12M

1,452.51%9.58M

201,300.00%2.01M

3,708.25%3.69M

6,351.67%3.87M

Net common stock issuance

-107.77%-87K

-88.85%1.07M

-100.05%-1K

-101.33%-49K

-100.03%-1K

--1.12M

--9.58M

--2.01M

--3.69M

--3.87M

Cash from discontinued financing activities

Financing cash flow

-107.77%-87K

-88.85%1.07M

-100.05%-1K

-101.33%-49K

-100.03%-1K

--1.12M

1,452.51%9.58M

201,300.00%2.01M

3,708.25%3.69M

6,351.67%3.87M

Net cash flow

Beginning cash position

-81.97%6.7M

-59.08%37.14M

-78.87%14.93M

-79.93%15.83M

-86.31%11.24M

-59.08%37.14M

-22.25%90.77M

-27.47%70.63M

-23.89%78.9M

-26.12%82.16M

Current changes in cash

98.84%-301K

43.22%-30.45M

75.43%-8.23M

89.04%-907K

240.78%4.59M

-200.93%-25.9M

-106.46%-53.62M

-406.21%-33.49M

-31.66%-8.27M

56.82%-3.26M

End cash Position

-43.12%6.4M

-81.97%6.7M

-78.87%14.93M

-79.93%15.83M

-86.31%11.24M

-59.08%37.14M

-27.47%70.63M

-23.89%78.9M

Free cash flow

32.19%-7.44M

12.37%-32.16M

28.69%-6.42M

53.93%-5.51M

-29.92%-9.26M

-27.46%-10.97M

-38.04%-36.7M

-36.06%-9M

-87.55%-11.97M

6.28%-7.13M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	32.19%-7.44M	12.37%-32.16M	28.69%-6.42M	53.93%-5.51M	-29.92%-9.26M	-27.46%-10.97M	-38.04%-36.7M	-36.06%-9M	-87.55%-11.97M	6.28%-7.13M
Net income from continuing operations	26.98%-8.39M	10.62%-39.48M	19.61%-9.16M	11.35%-9.86M	23.64%-8.97M	-15.98%-11.49M	-40.97%-44.17M	-41.21%-11.4M	-15.52%-11.13M	-52.84%-11.74M
Other non cash items	-10.81%33K	-2.79%174K	-28.57%25K	114.29%75K	-43.08%37K	-15.91%37K	5.92%179K	-20.45%35K	-18.60%35K	54.76%65K
Change In working capital	85.98%-135K	1,946.38%1.27M	36.64%869K	202.28%2.92M	-153.92%-1.55M	-33.01%-963K	94.69%-69K	312.00%636K	-265.79%-2.85M	259.04%2.87M
-Change in prepaid assets	-64.65%327K	225.25%2.62M	-33.97%383K	178.11%2.31M	-219.30%-989K	267.27%925K	-193.83%-2.1M	1,015.38%580K	-264.22%-2.95M	142.45%829K
-Change in payables and accrued expense	77.42%-487K	-216.55%-2.57M	-88.52%24K	37.55%315K	-139.70%-752K	-1,598.43%-2.16M	81.48%2.21M	239.33%209K	-88.79%229K	263.28%1.89M
-Change in other current liabilities	-8.11%-40K	36.31%-114K	54.29%-16K	31.43%-24K	43.08%-37K	15.91%-37K	-5.92%-179K	20.45%-35K	18.60%-35K	-54.76%-65K
-Change in other working capital	-78.76%65K	--1.33M	--478K	443.01%319K	--231K	--306K	----	----	95.52%-93K	----
Cash from discontinued investing activities
Operating cash flow	32.19%-7.44M	12.37%-32.16M	28.69%-6.42M	53.93%-5.51M	-29.92%-9.26M	-27.46%-10.97M	-38.04%-36.7M	-36.06%-9M	-87.55%-11.97M	6.28%-7.13M
Investing cash flow
Cash flow from continuing investing activities	145.01%7.22M	102.46%651K	93.18%-1.81M	4.66M	13.85M	-16.05M	-26.5M	-26.5M	0	0
Net investment purchase and sale	145.01%7.22M	102.46%651K	93.18%-1.81M	--4.66M	--13.85M	---16.05M	---26.5M	---26.5M	--0	--0
Cash from discontinued investing activities
Investing cash flow	145.01%7.22M	102.46%651K	93.18%-1.81M	--4.66M	--13.85M	---16.05M	---26.5M	---26.5M	--0	--0
Financing cash flow
Cash flow from continuing financing activities	-107.77%-87K	-88.85%1.07M	-100.05%-1K	-101.33%-49K	-100.03%-1K	1.12M	1,452.51%9.58M	201,300.00%2.01M	3,708.25%3.69M	6,351.67%3.87M
Net common stock issuance	-107.77%-87K	-88.85%1.07M	-100.05%-1K	-101.33%-49K	-100.03%-1K	--1.12M	--9.58M	--2.01M	--3.69M	--3.87M
Cash from discontinued financing activities
Financing cash flow	-107.77%-87K	-88.85%1.07M	-100.05%-1K	-101.33%-49K	-100.03%-1K	--1.12M	1,452.51%9.58M	201,300.00%2.01M	3,708.25%3.69M	6,351.67%3.87M
Net cash flow
Beginning cash position	-81.97%6.7M	-59.08%37.14M	-78.87%14.93M	-79.93%15.83M	-86.31%11.24M	-59.08%37.14M	-22.25%90.77M	-27.47%70.63M	-23.89%78.9M	-26.12%82.16M
Current changes in cash	98.84%-301K	43.22%-30.45M	75.43%-8.23M	89.04%-907K	240.78%4.59M	-200.93%-25.9M	-106.46%-53.62M	-406.21%-33.49M	-31.66%-8.27M	56.82%-3.26M
End cash Position	-43.12%6.4M	-81.97%6.7M	-81.97%6.7M	-78.87%14.93M	-79.93%15.83M	-86.31%11.24M	-59.08%37.14M	-59.08%37.14M	-27.47%70.63M	-23.89%78.9M
Free cash flow	32.19%-7.44M	12.37%-32.16M	28.69%-6.42M	53.93%-5.51M	-29.92%-9.26M	-27.46%-10.97M	-38.04%-36.7M	-36.06%-9M	-87.55%-11.97M	6.28%-7.13M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall